The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (7.41) USD. With the latest stock price at 1.18 USD, the upside of Cytosorbents Corp based on DCF is -727.6%.
Based on the latest price of 1.18 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 727.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.3% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (33.70) - (4.31) | (7.41) |
| Upside | -2956.0% - -465.5% | -727.6% |